.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Chinese Patent Office
Argus Health
Julphar
Queensland Health
Dow
Citi
McKesson
Cantor Fitzgerald
Accenture

Generated: December 18, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: indium in-111 pentetate disodium

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Ge HealthcareMPI INDIUM DTPA IN 111indium in-111 pentetate disodiumINJECTABLE;INTRATHECAL017707NDAMedi-Physics, Inc. dba GE Healthcare17156-251-081.5 mL in 1 VIAL, GLASS (17156-251-08)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Moodys
Queensland Health
QuintilesIMS
Baxter
Federal Trade Commission
Healthtrust
McKesson
Citi

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot